Journal of the National Cancer Institute Journal

Overview
Identity
View All

publication venue for

The Role of Regional and Practice Trial Sites in Non-Representative Randomized Cancer Trial Enrollment.. 117:2672-2676. 2025
Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer. 2025
Diagnostic yield of surveillance mammography among older women. 2025
Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer.. 117:1465-1473. 2025
Gerotherapeutics: aging mechanism-based pharmaceutical and behavioral interventions to reduce cancer racial and ethnic disparities.. 117:406-422. 2025
Physical Activity and Cognition: Longitudinal findings from the Thinking and Living with Cancer Study.. 116:2009-2021. 2024
Alzheimer disease-related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study.. 116:1495-1507. 2024
Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older.. 116:81-96. 2024
Geriatric assessment and management: is decreasing treatment toxicity good enough?. 115:1445-1447. 2023
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.. 115:981-988. 2023
Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiative.. 115:680-694. 2023
Toxicity Risk Score and Clinical Decline After Adjuvant Chemotherapy in Older Breast Cancer Survivors.. 115:578-585. 2023
Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.. 114:1484-1491. 2022
Policies and Practices to Address Cancer's Long-Term Adverse Consequences.. 114:1065-1071. 2022
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.. 114:854-862. 2022
Receptivity to a Nurse-Led Symptom Management Intervention Among Highly Symptomatic Patients With Cancer.. 114:458-466. 2022
Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old.. 113:1515-1522. 2021
Response to Dekker, Stege, and Versteeg.. 113:1436-1437. 2021
Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation.. 113:1405-1414. 2021
Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study.. 113:1053-1064. 2021
Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma.. 113:1084-1093. 2021
Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond.. 113:355-359. 2021
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults.. 113:258-265. 2021
Temporal Trends in Opioid Prescribing Patterns Among Oncologists in the Medicare Population.. 113:274-281. 2021
Strategies to Prevent or Remediate Cancer and Treatment-Related Aging.. 113:112-122. 2021
Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen Levels.. 112:384-390. 2020
Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors.. 111:1245-1254. 2019
Integrating Assessment of Sarcopenia into Decision-making for Allogeneic Hematopoietic Cell Transplantation: Ready for Prime Time?. 111:757-759. 2019
Randomized Trial of the Impact of Empowering Childhood Cancer Survivors With Survivorship Care Plans.. 110:1352-1359. 2018
Use of Alternative Medicine for Cancer and Its Impact on Survival.. 110. 2018
The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer.. 109. 2017
Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.. 108. 2015
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).. 107:-. 2014
Response.. 106. 2014
Evolution of breast cancer screening in the Medicare population: clinical and economic implications.. 106. 2014
Multiple myeloma in the very old: an IASIA conference report.. 106. 2014
Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.. 106:-. 2014
Sex hormone levels and risk of breast cancer with estrogen plus progestin.. 105:1496-503. 2013
Response.. 105:748-9. 2013
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.. 105:25-32. 2012
Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.. 104:581-9. 2012
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.. 103:562-70. 2011
Functional assessment and the cancer survivor: something old, something new.. 102:1450-1. 2010
Effectiveness of radiation therapy in older women with ductal carcinoma in situ.. 98:1302-10. 2006
Effectiveness of radiation therapy for older women with early breast cancer.. 98:681-90. 2006